Literature DB >> 23634424

A secondary carcinomatous lesion masquerading as a primary osteosarcoma - a case report.

Thamilselvi Ramachandran1, P M Subramanium, K Prakasam.   

Abstract

Penile carcinomas account for 10% of all the malignancies in men with a predominant regional lymph node involvement, but a distant metastasis of such a carcinoma via the haematogenous route is rare (2.3%), with the common sites being the kidneys, adrenal glands, retroperitoneal lymph nodes, lungs, brain and the dorsal spine. The pattern of the metastatic spread from carcinomas of the penis has been well described in the literature, with the inguinal and the iliac nodes being the commonest sites. The distant metastases are uncommon and delayed, even in advanced disease. Although metastases to the liver and lungs have been reported, the osseous metastases are exceptionally rare. We are presenting a case of carcinoma of the penis which metastasized to the tibia.

Entities:  

Keywords:  Osteosarcoma & Squamous cell carcinoma; Penile carcinoma

Year:  2013        PMID: 23634424      PMCID: PMC3616584          DOI: 10.7860/JCDR/2013/4098.2826

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  4 in total

1.  Carcinoma of the penis.

Authors:  W J STAUBITZ; M H LENT; O J OBERKIRCHER
Journal:  Cancer       Date:  1955 Mar-Apr       Impact factor: 6.860

2.  Cancer of the penis.

Authors:  M RIVEROS; R GOROSTIAGA
Journal:  Arch Surg       Date:  1962-09

3.  [Metastasis of penile cancer to the ischial bone].

Authors:  R I Gun'ko; S D Fomin
Journal:  Med Radiol (Mosk)       Date:  1989-01

4.  Cancer profile in eastern Rajasthan.

Authors:  R G Sharma; R Ajmera; O Saxena
Journal:  Indian J Cancer       Date:  1994-09       Impact factor: 1.224

  4 in total
  1 in total

1.  Pathological Fracture of the Femur by Metastatic Carcinoma Penis-a Rare Presentation.

Authors:  Shabbir Hussain; Fanindra Singh Solanki; Deepti B Sharma; Dhananjay Sharma
Journal:  Indian J Surg       Date:  2015-10-30       Impact factor: 0.656

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.